The DOI matches its Crossref record.
Analysis of the Melanoma Epidemic, Both Apparent and Real: Data From the 1973 Through 1994 Surveillance, Epidemiology, and End Results Program Registry
Abstract
BACKGROUND: The incidence of melanoma has been increasing faster than that of any other cancer in the United States. It is unclear whether the increase is related to increased surveillance or other changes in the disease. OBJECTIVE: To examine changes in melanoma rates by several measures of severity of disease and to review the ways in which increased surveillance may cause lead-time bias through early detection or length bias through detection of clinically insignificant lesions as a basis for interpreting these changing rates. DESIGN: Population-based incidence rates for 1973 through 1994. SETTING: United States Surveillance, Epidemiology, and End Results Program tumor registries. PATIENTS: A total of 47,638 cases of melanoma among white patients aged 20 years and older. MAIN OUTCOME MEASURES: Relative incidence rates for melanoma by stage, and tumor thickness adjusted for age and sex. RESULTS: Localized-stage melanoma increased, but no significant change for distant-stage melanomas was seen. Among those diagnosed from 1988 through 1994, there were 22%, 26%, and 31% increases for tumor thickness less than 1.0 mm, between 1.0 and 3.0 mm, and 3.0 mm or greater, respectively. The 2-year mortality rates also increased over time. CONCLUSIONS: While these data show large increases in early disease (localized stage, thin tumors), they also suggest some increase in advanced disease (thick tumors, 2-year mortality). This indicates that the increasing incidence rates of melanoma are not solely caused by increased early detection and diagnosis of clinically insignificant melanomas, but may also represent a true increase in cancer rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,599
Increasing Burden of Melanoma in the United States
Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., & Clarke, C. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.423 · Cited by 746
Melanoma epidemiology and trends
Garbe, C., & Leiter, U. (2009) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.001 · Cited by 657
Epidemiological trends in skin cancer
Apalla, Z., Lallas, A., Sotiriou, E., Lazaridou, E., & Ioannides, D. (2017) · Dermatology Practical & Conceptual · doi:10.5826/dpc.0702a01 · Cited by 628
Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches
Apalla, Z., Nashan, D., Weller, R. B., & Castellsagué, X. (2017) · Dermatology and Therapy · doi:10.1007/s13555-016-0165-y · Cited by 465
Recent Trends in Cutaneous Melanoma Incidence Among Whites in the United States
Jemal, A., Devesa, S. S., Hartge, P., & Tucker, M. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.678 · Cited by 449
de Vries, E., Bray, F. I., Coebergh, J. W. W., Parkin, D. M., & European Network of Cancer Registries (2003) · International Journal of Cancer · doi:10.1002/ijc.11360 · Cited by 378
Cutaneous malignant melanoma in Europe
de Vries, E., & Willem Coebergh, J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.003 · Cited by 266
Predictions of skin cancer incidence in the Netherlands up to 2015
de Vries, E., van de Poll-Franse, L. V., Louwman, W. J., de Gruijl, F. R., & Coebergh, J. W. W. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06386.x · Cited by 253
(2003) · PubMed · Cited by 183
Skin diseases in family medicine: prevalence and health care use.
Verhoeven, E. W. M., Kraaimaat, F. W., van Weel, C., van de Kerkhof, P. C. M., Duller, P., van der Valk, P. G. M., van den Hoogen, H. J. M., Bor, J. H. J., Schers, H. J., & Evers, A. W. M. (2008) · The Annals of Family Medicine · doi:10.1370/afm.861 · Cited by 80
Vitamin A Intake and Risk of Melanoma: A Meta-Analysis
Zhang, Y.-P., Chu, R.-X., & Liu, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102527 · Cited by 36
Metadata
- Authors
- Dennis, L. K.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 1999-03-01
- Volume
- 135
- Issue
- 3
- Pages
- 275-80
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2141439220
- Cited by
- 193
- References
- 0
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.